These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 3528901)

  • 21. Ketamine anaesthesia has no effect on striatal dopamine metabolism in rats.
    Koshikawa N; Tomiyama K; Omiya K; Kobayashi M
    Brain Res; 1988 Mar; 444(2):394-6. PubMed ID: 3359305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-induced changes in the formation, storage and metabolism of tyramine in the mouse.
    Juorio AV
    Br J Pharmacol; 1979 Jul; 66(3):377-84. PubMed ID: 43172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of long-term L-dopa administration on striatal extracellular dopamine release.
    Brannan T; Martinez-Tica J; Yahr MD
    Neurology; 1991 Apr; 41(4):596-8. PubMed ID: 2011263
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postnatal development of dopamine deamination in the striatum of the rat.
    Davis AJ; Holzbauer M; Sharman DF
    Br J Pharmacol; 1975 Dec; 55(4):558-60. PubMed ID: 1212563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tyrosine administration increases striatal dopamine release in rats with partial nigrostriatal lesions.
    Melamed E; Hefti F; Wurtman RJ
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):4305-9. PubMed ID: 6254020
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of administration of meta-tyramine and para-tyramine on dopamine and its metabolites in the rat striatum.
    McQuade PS; Wood PL
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):705-9. PubMed ID: 6531442
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 3-O-methyldopa blocks dopa metabolism in rat corpus striatum.
    Reches A; Fahn S
    Ann Neurol; 1982 Sep; 12(3):267-71. PubMed ID: 7137962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tyrosine: effects on catecholamine release.
    Acworth IN; During MJ; Wurtman RJ
    Brain Res Bull; 1988 Sep; 21(3):473-7. PubMed ID: 3214752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic activity is reduced in diabetic rats.
    Saller CF
    Neurosci Lett; 1984 Aug; 49(3):301-6. PubMed ID: 6493613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of halothane dose on striatal dopamine: an in vivo microdialysis study.
    Miyano K; Tanifuji Y; Eger EI
    Brain Res; 1993 Mar; 605(2):342-4. PubMed ID: 8481785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Haloperidol: effect of long-term treatment on rat striatal dopamine synthesis and turnover.
    Lerner P; Nosé P; Gordon EK; Lovenberg W
    Science; 1977 Jul; 197(4299):181-3. PubMed ID: 17917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Striatal adenosine A(2A) receptor blockade increases extracellular dopamine release following l-DOPA administration in intact and dopamine-denervated rats.
    Gołembiowska K; Dziubina A
    Neuropharmacology; 2004 Sep; 47(3):414-26. PubMed ID: 15275831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effects of the administration of beta-phenylethylamine on tyramine metabolism.
    McQuade PS; Juorio AV
    Eur J Pharmacol; 1982 Sep; 83(3-4):277-82. PubMed ID: 7173310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in striatal dopamine metabolism after microsphere embolism in rats.
    Takagi N; Tsuru H; Yamamura M; Takeo S
    Stroke; 1995 Jun; 26(6):1101-6. PubMed ID: 7762029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopaminergic dysfunction in neonatal hypothyroidism: differential effects of GM1 ganglioside.
    Vaccari A; Stefanini E; de Montis G; Rossetti ZL
    Neuropharmacology; 1990 Dec; 29(12):1161-9. PubMed ID: 2149873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of administration of monoamine oxidase-B inhibitors on rat striatal neurone responses to dopamine.
    Berry MD; Scarr E; Zhu MY; Paterson IA; Juorio AV
    Br J Pharmacol; 1994 Dec; 113(4):1159-66. PubMed ID: 7889269
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral decarboxylation of meta- and para-tyrosine.
    Boulton AA; Juorio AV
    Experientia; 1983 Feb; 39(2):130-4. PubMed ID: 6832285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholecystokinin attenuates basal and drug-induced increases of limbic and striatal dopamine release.
    Altar CA; Boyar WC; Oei E; Wood PL
    Brain Res; 1988 Sep; 460(1):76-82. PubMed ID: 3219572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine receptor binding is increased in diabetic rats.
    Lozovsky D; Saller CF; Kopin IJ
    Science; 1981 Nov; 214(4524):1031-3. PubMed ID: 6458088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vivo studies of striatal dopamine release and metabolism following administration of L-dopa.
    Brannan T; Knott P; Kaufmann H; Yahr M
    Adv Neurol; 1990; 53():75-81. PubMed ID: 2173378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.